As the potential fourth vaccine for COVID-19 passes benchmarks after months of delays and halted funding at the end of 2021, The Hill summarized three facts about Novavax June 14:
Read the full post on Becker's Hospital Review - Healthcare News
3 notes on the Novavax COVID-19 vaccine
